PortViewPortView
MedTech Acquisition logo

MedTech Acquisition (MTACU) Stock Analysis

NASDAQFinancial ServicesShell Companies

$11.35+12.94%
1-year price historyRange $9.50 – $11.43
52-week range$11.35
$9.23$11.43

What MedTech Acquisition does

MedTech Acquisition Corporation currently lacks substantial business operations. Its primary objective is to execute a strategic business combination, such as a merger, acquisition of assets or stock, or a corporate reorganization, with one or more entities operating within the healthcare sector in the United States. This Greenwich, Connecticut-based company was established in 2020.

Key metrics

Market cap
$84.29M
P/E (TTM)
44.51
EPS (TTM)
$0.26
Beta
-0.04
Dividend yield
0.00%
Revenue / share
$0.77
50-day avg
$10.21
200-day avg
$10.16
52-week high
$11.43
52-week low
$9.23
CEO
Christopher C. Dewey

ETFs linked to MTACU

Broad-market and Financial Services sector ETFs an investor holding MedTech Acquisition is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MTACU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MTACU in PortView →

Frequently asked questions

What is the ticker symbol for MedTech Acquisition?
MedTech Acquisition trades under the ticker MTACU on NASDAQ.
Which exchange is MTACU listed on?
MTACU is listed on NASDAQ.
What sector does MedTech Acquisition operate in?
MedTech Acquisition is classified in the Financial Services sector (Shell Companies industry).
How can PortView help analyze MTACU in a portfolio?
PortView shows MTACU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.